Territory Sales Manager New York City Metro
Boost your chances before you apply.
AngioSafe
New York, NY, US
Summary
The Territory Sales Manager will drive the commercialization of catheter technology by conducting sales calls and building relationships with key healthcare stakeholders. They are responsible for executing sales strategies, providing clinical support, and managing accounts within the New York City Metro territory.
Job Description
AngioSafe is a Bay Area medical device company focused on improving healthcare delivery through state-of-the-art catheter development. Our seasoned experts are committed to producing high-quality, innovative products designed to decrease risk and improve outcomes in the treatment of arterial disease.We are seeking an experienced Territory Sales Manager to drive and support the commercialization of our innovative catheter technology across the New York City Metro sales territory.Roles and Responsibilities
- Conduct sales calls to healthcare professionals to promote AngioSafe medical devices.
- Build, cultivate, and maintain strong relationships with key stakeholders at hospitals, office-based labs (OBLs), and ambulatory surgical centers (ASCs).
- Provide product information, demonstrations, and clinical support to healthcare professionals.
- Analyze market trends and customer needs to develop and execute effective sales strategies.
- Provide regular reports on sales performance, forecasts, and market conditions to leadership.
- Stay informed of industry regulations, product innovations, clinical developments, and the competitive landscape.
- Negotiate contracts and close sales opportunities.
- Attend medical conferences and industry events to develop relationships with potential customers and key opinion leaders.
Skills, Experience, Education & Behaviors
- Bachelor’s degree in Business, Marketing, Healthcare, or a related field; MBA or advanced degree a plus.
- Award-winning and proven track record in medical device sales (7–10 years), preferably in peripheral or coronary interventions or endovascular markets.
- In-depth knowledge of vascular anatomy, disease states including PAD and CTO, and procedural workflows.
- Established relationships within the NYC Metro market with interventional cardiologists, vascular surgeons, and/or interventional radiologists strongly preferred.
- Demonstrated experience navigating Value Analysis Committees (VACs) and supply chain.
- Ability to manage office-based labs (OBLs), ambulatory surgical centers (ASCs), and hospital accounts.
- Demonstrated business acumen with consistent overachievement of sales quotas in capital and/or disposable medical device sales.
- Ability to execute strategic territory planning, identify high-potential accounts, and displace competitive products.
- Skilled in physician education and procedural case support in Cath Lab and/or OR settings.
- Ability to independently support procedures and confidently guide physicians step-by-step through the use of a medical device during live cases.
- Ability to train physicians and staff on device use and procedural integration.
- Strong aptitude for troubleshooting during live cases.
- Comfortable discussing device mechanism of action and clinical data with physicians and other healthcare professionals.
- Experience with competitive economic selling, including ROI modeling and reimbursement knowledge.
- Adept at creating multi-touch account penetration strategies involving physicians, administration, and supply chain.
- Understanding of the competitive landscape, including wires, atherectomy, IVL, CTO crossing devices, balloons, and stents.
- Self-starter with a hunter mentality and a demonstrated ability to open new accounts, not simply maintain existing business.
- Resilient and effective in long sales cycles involving multiple decision-makers.
- High-energy, credible presence in the lab and confidence interacting with KOLs and participating in clinical discussions.
- Ability and willingness to travel extensively throughout the territory and occasionally nationally for key meetings.
- Team player who is coachable and committed to continued professional development.
- Demonstrated ability to work independently and with inherent initiative.
- Proficiency with Microsoft Office Suite and project management tools.
Compensation & BenefitsAngioSafe offers competitive compensation (Base + Bonus) and benefits. Pay for the successful candidate will depend on various factors, including qualifications, education, prior experience, and geography.Benefits include:
- Medical, Dental, Vision & Life Insurance
- Paid Time Off + Holidays
- Remote Work Environment
- 401(k)
- Company Equity
Principals only, please.AngioSafe is committed to a diverse workplace and to equal employment opportunity for all job applicants without regard to race, color, religion, sex, sexual orientation, age, gender, gender identity or expression, size, national origin, disability, or veteran status. AngioSafe complies with all applicable local, state, and national laws governing nondiscrimination in employment
AngioSafe® is redefining revascularization through the development of technologies that safely, efficiently, and predictably empower interventionalists to tackle complex lesions. Its proprietary Atheroplasty™ core technology platform does not require any capital equipment and simultaneously combines mechanisms and features to revascularize severely occluded arteries, simplifying one of the most complex procedures in cardiovascular interventions.
With its flagship Santreva™-ATK endovascular revascularization catheter, AngioSafe is advancing a new era of vascular innovation to improve procedure outcomes and confidence for physicians addressing complex femoropopliteal interventions.
Santreva-ATK is FDA cleared and CE marked and is now commercially available.
Founded
2014
Company size
51-200 employees
Industry
Medical Device
Org type
Privately Held
Headquarters
San Jose, California
AngioSafe® is redefining revascularization through the development of technologies that safely, efficiently, and predictably empower interventionalists to tackle complex lesions. Its proprietary Atheroplasty™ core technology platform does not require any capital equipment and simultaneously combines mechanisms and features to revascularize severely occluded arteries, simplifying one of the most complex procedures in cardiovascular interventions.
With its flagship Santreva™-ATK endovascular revascularization catheter, AngioSafe is advancing a new era of vascular innovation to improve procedure outcomes and confidence for physicians addressing complex femoropopliteal interventions.
Santreva-ATK is FDA cleared and CE marked and is now commercially available.
Founded
2014
Company size
51-200 employees
Industry
Medical Device
Org type
Privately Held
Headquarters
San Jose, California